Test / Trial definition

Test / Trial means such tests as are prescribed in specifications to be made by the Purchaser or his nominee.
Sample 1Sample 2Sample 3
Test / Trial means such tests as are prescribed in specifications to be made by the Purchaser or his nominee, after assembly ex-works before the equipment is installed by the tenderer as well as the tests to be performed before installation and commissioning.
Sample 1Sample 2Sample 3
Test / Trial means such tests as are prescribed in specifications of Main engines, Gear Boxes, ASD, Steering system and all other machineries / systems / items installed onboard.
Sample 1Sample 2Sample 3

Examples of Test / Trial in a sentence

  • The LCE&S support activities include; but, not limited to:Assist in evolving and supporting the related tasks of logistics management, maintenance, supply support, technical design interface, facilities, technical data, and personnel as it relates to ships production, permanently installed ship mission systems, Post Delivery and Test & Trial (PDT&T) of the LCS Ships.

  • Ireland could seek to differentiate itself by becoming a test bed of test beds for trial and validation of “Future Networks & Communications” technologies.Building on existing test beds such as SmartBay, Exemplar, Comreg Test & Trial and the IMS Carrier Grade test bed would make Ireland an even more attractive location for potential FDI clients.

  • They shall be supplementary to the Frame Agreement and consist of the “Commercial Agreement” itself and its Local Annexes e.g.: - Commercial Agreements concerning the purchase of commercially traded Products & Local Annexes Commercial Agreements for UMTS Products based on 3GPP (Test & Trial) & Local Annexes Both Parties confirm, that they are in possession of the above-mentioned documents of the Frame Agreement.

  • The National Comprehensive Risk Management and Civil Protection System was established pursuant to Act No. 27.287 and will be used to coordinate the efforts of national government agencies, provincial governments, the Autonomous City of Buenos Aires, municipal governments, non-governmental organizations and civil society to optimize risk reduction, crisis management and recovery activities.

  • Dedicated Test & Trial team formed for smooth organising& conducting of HATs & SATs.

  • Evaluation (Test/Trial) Expenditure The Bidder / Firm shall be liable for all expenses pertaining to Test / Trial during Evaluation process.

  • Any such loss of function during testing shall be recorded in the Test / Trial Report.

  • The date of commencement of the O & M Contract will be the date on which the Charge is handed over to the Private Partner by CGSMFPCFL after successful Test & Trial Run of the Plant.

  • This entry is submitted on the foregoing representation and agreement.Signature of owner or the agent duly authorized to make this entryTelephone: email: AGREEMENTI (we) acknowledge that the American Herding Breed Association Rules for Herding Tests & Trials have been made available to me (us) and that I (we) agree that the club holding the Herding Test & Trial has the right to refuse this entry for cause which the club shall deem to be sufficient.

  • Design and Development of test rig for vibration loosening of bolts then manufacturing and assembly of test rig .Design and development of system components for interchangeability of bolts namely ( M4 , M5 , M6 , &M8) Test & Trial on test rig to develop the loosening characteristics of bolts and derive the decay graphs versus cycles.

Related to Test / Trial

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.

  • Phase 2 Trial means a human clinical trial conducted on study subjects with the disease or condition being studied for the principal purpose of achieving a preliminary determination of efficacy or appropriate dosage ranges, as further described in 21 C.F.R. §312.21(b) (including any such clinical study in any country other than the United States).

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • DNA profile means a letter or number code which represents a set of identification characteristics of the non-coding part of an analysed human DNA sample, i.e. the particular molecular structure at the various DNA locations (loci);

  • Phase 3 Trial means a human clinical trial of a Product on a sufficient number of subjects that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which trial is intended to support Approval of a Product, as described in 21 C.F.R. 312.21(c) for the United States, or a similar clinical study prescribed by the Regulatory Authorities in a foreign country.

  • Phase 1 Trial means, with respect to a Licensed Product, a clinical trial (or — in case of a multi-phase clinical trial — those parts of a clinical trial) in line with the provisions of 21CFR312, Section 21 (a).

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Cannabis testing facility means an entity registered by

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • Treatability study means a study in which a hazardous waste is subjected to a treatment process to determine: (1) Whether the waste is amenable to the treatment process, (2) what pretreatment (if any) is required, (3) the optimal process conditions needed to achieve the desired treatment, (4) the efficiency of a treatment process for a specific waste or wastes, or (5) the characteristics and volumes of residuals from a particular treatment process. Also included in this definition for the purpose of the § 261.4 (e) and (f) exemptions are liner compatibility, corrosion, and other material compatibility studies and toxicological and health effects studies. A “treatability study” is not a means to commercially treat or dispose of hazardous waste.

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Test Issue means any variance or non-conformity of the Services or Deliverables from their requirements as set out in the Call Off Contract;

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Test cycle means a sequence of test points each with a defined speed and torque to be followed by the engine under steady state (WHSC) or transient operating conditions (WHTC).

  • Test Fail has the meaning stated in Section 3.4(a).

  • Home study means the assessment process used for the purpose of determining the ability of an applicant to care for a child in need of foster care placement.

  • Pivotal Clinical Trial means, with respect to a Licensed Product, (a) a phase 3 Clinical Trial or (b) any other clinical trial that is intended (as of the time the study is initiated) to obtain the results and data to support (without the need to conduct any additional clinical trial) the filing of an application for Regulatory Approval for such product.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Phase I Clinical Trial means a clinical trial conducted in healthy humans or patients, which clinical trial is designed to establish the safety, drug-drug interactions and/or pharmacokinetics of an investigational drug given its intended use, and to support continued testing of such drug in Phase II Clinical Trials.

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • Screening Test means a drug or alcohol test which uses a method of analysis allowed by the Minnesota Drug and Alcohol Testing in the Workplace Act to be used for such purposes.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • DNS test Means one non-­‐recursive DNS query sent to a particular “IP address” (via UDP or TCP). If DNSSEC is offered in the queried DNS zone, for a query to be considered answered, the signatures must be positively verified against a corresponding DS record published in the parent zone or, if the parent is not signed, against a statically configured Trust Anchor. The answer to the query must contain the corresponding information from the Registry System, otherwise the query will be considered unanswered. A query with a “DNS resolution RTT” 5 times higher than the corresponding SLR, will be considered unanswered. The possible results to a DNS test are: a number in milliseconds corresponding to the “DNS resolution RTT” or, undefined/unanswered.

  • Phase II Study means a study in humans of the safety, dose ranging or efficacy of a product, as further defined in 21 C.F.R. § 312.21(b) (or the equivalent thereof outside the United States).

  • RDDS test Means one query sent to a particular “IP address” of one of the servers of one of the RDDS services. Queries shall be about existing objects in the Registry System and the responses must contain the corresponding information otherwise the query will be considered unanswered. Queries with an RTT 5 times higher than the corresponding SLR will be considered as unanswered. The possible results to an RDDS test are: a number in milliseconds corresponding to the RTT or undefined/unanswered.